These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3890772)

  • 1. Immunohistological detection of human malignant melanoma using monoclonal antibody to a melanoma-associated antigen.
    Kageshita T; Johno M; Ono T; Arao T; Imai K
    Arch Dermatol Res; 1985; 277(4):334-6. PubMed ID: 3890772
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigens associated with tumor progression in melanocytic neoplasia.
    Elder DE; Herlyn M
    Pigment Cell Res; 1992; Suppl 2():136-43. PubMed ID: 1409415
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure and epitope specificity of human melanoma-associated oncofetal antigen gp87 analyzed with monoclonal antibodies.
    Liao SK; Leung WC; Kanamaru T
    J Dermatol; 1985 Apr; 12(2):117-28. PubMed ID: 2411774
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic profile of human melanoma cells. Analysis with monoclonal antibodies to histocompatibility antigens and to melanoma-associated antigens.
    Natali PG; Giacomini P; Russo C; Steinbach G; Fenoglio C; Ferrone S
    J Cutan Pathol; 1983 Aug; 10(4):225-37. PubMed ID: 6350388
    [No Abstract]   [Full Text] [Related]  

  • 5. [Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology].
    Monti M; Berti E; Cavicchini S; Paindelli MG; Terragni L
    G Ital Dermatol Venereol; 1985; 120(4):297-306. PubMed ID: 3899920
    [No Abstract]   [Full Text] [Related]  

  • 6. Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections.
    Imam A; Mitchell MS; Modlin RL; Taylor CR; Kempf RA; Kan-Mitchell J
    J Invest Dermatol; 1986 Feb; 86(2):145-8. PubMed ID: 3528308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial distribution of a myelomonocytic antigen LI in relation to cutaneous malignancies and melanocytic naevi.
    Gabrielsen TO; Brandtzaeg P; Hoel PS; Dale I
    Br J Dermatol; 1988 Jan; 118(1):59-67. PubMed ID: 3277660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma antigens: immunological and biological characterization and clinical significance.
    Herlyn M; Koprowski H
    Annu Rev Immunol; 1988; 6():283-308. PubMed ID: 3289568
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of monoclonal antibodies on the study of human malignant melanoma.
    Natali PG; Aguzzi A; Veglia F; Imai K; Burlage RS; Giacomini P; Ferrone S
    J Cutan Pathol; 1983 Dec; 10(6):514-28. PubMed ID: 6198345
    [No Abstract]   [Full Text] [Related]  

  • 10. An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.
    Gatter KC; Ralfkiaer E; Skinner J; Brown D; Heryet A; Pulford KA; Hou-Jensen K; Mason DY
    J Clin Pathol; 1985 Dec; 38(12):1353-7. PubMed ID: 3908491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoplastic meningitis in malignant melanoma: diagnosis with monoclonal antibodies.
    Moseley RP; Davies AG; Bourne SP; Popham C; Carrel S; Monro P; Coakham HB
    J Neurol Neurosurg Psychiatry; 1989 Jul; 52(7):881-6. PubMed ID: 2671265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
    Jungbluth AA; Busam KJ; Gerald WL; Stockert E; Coplan KA; Iversen K; MacGregor DP; Old LJ; Chen YT
    Am J Surg Pathol; 1998 May; 22(5):595-602. PubMed ID: 9591730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the antigen recognized by mAb GB36 in normal skin and in skin tumours.
    Hofman P; Lacour JP; Emiliozzi C; Staquet MJ; Hsi BL; Rossi B; Ortonne JP
    Br J Dermatol; 1995 Dec; 133(6):874-83. PubMed ID: 8547038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of human monoclonal antibody (2-139-1) in cutaneous melanocytic neoplasms in fixed tissue sections.
    White WL; Tam ST; Mitchell MS; Yu MC; Kan-Mitchell J
    J Histochem Cytochem; 1991 Jun; 39(6):777-85. PubMed ID: 1709658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple assay characterization of murine monoclonal antimelanoma antibodies.
    Stuhlmiller GM; Borowitz MJ; Croker BP; Seigler HF
    Hybridoma; 1982; 1(4):447-60. PubMed ID: 6208139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the binding characteristics of monoclonal antimelanoma antibodies.
    Herlyn M; Steplewski Z; Atkinson BF; Ernst CS; Koprowski H
    Hybridoma; 1982; 1(4):403-11. PubMed ID: 6765323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue specificity of anti melanoma monoclonal antibodies analyzed on cell lines.
    Johnson JP; Riethmüller G
    Hybridoma; 1982; 1(4):381-5. PubMed ID: 6208134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher cytolytic efficiency of an IgG2 alpha than of an IgG1 monoclonal antibody reacting with the same (or spatially close) determinant on a human high-molecular-weight melanoma-associated antigen.
    Imai K; Pellegrino MA; Wilson BS; Ferrone S
    Cell Immunol; 1982 Sep; 72(2):239-47. PubMed ID: 6185235
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical application of monoclonal antibodies to human malignant melanoma-associated antigens].
    Kageshita T; Ishihara K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1744-8. PubMed ID: 3899015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Workshop on monoclonal antibodies to human melanoma-associated antigens: findings of the Seattle group.
    Hellström I; Brown JP; Hellström KE
    Hybridoma; 1982; 1(4):399-402. PubMed ID: 6208136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.